Remenar, Lin Lin

Remenar, Lin Lin was paid $188K by Medicaid between Jan 2018 and May 2023, across 10 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 66% of everything it billed.

33Billing provider infoREMENAR, LIN LIN
MIDDLETOWN, NY 10941

33aNPI1417025321assigned 11/30/2006

33bProvider typePediatrics Physician

28Total paid$188K

24GClaims2,694

24DCodes billed10

24AFirst – last monthJan 2018 – May 2023

Compared with peers

Next to other Pediatrics Physician providers in New York

Rank by total paid#583 of 1,983

Median peer was paid$17K

This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	56	$5K
2019	262	$12K
2020	695	$35K
2021	780	$64K
2022	830	$66K
2023	71	$6K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	66%	1,347	1,221	$124K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	13%	210	203	$25K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	13%	180	177	$24K
90460	Immunization administration through 18 years of age via any route, first or only component	5.6%	549	525	$11K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	13	13	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	23	23	$2K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	17	14	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	23	23	$500.00
92551		<1%	139	138	$450.56
90686		<1%	193	191	$178.57

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.